We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · August 19, 2015

Pembrolizumab Cutaneous Adverse Events and Disease Progression

JAMA Dermatology

 

Additional Info

JAMA Dermatology
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
JAMA Dermatol 2015 Jul 29;[EPub Ahead of Print], M Sanlorenzo, I Vujic, A Daud, A Algazi, M Gubens, SA Luna, K Lin, P Quaglino, K Rappersberger, S Ortiz-Urda

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading